Literature DB >> 15451907

The effect of diabetes on B-type natriuretic peptide concentrations in patients with acute dyspnea: an analysis from the Breathing Not Properly Multinational Study.

Alan H B Wu1, Torbjørn Omland, Philippe Duc, James McCord, Richard M Nowak, Judd E Hollander, Howard C Herrmann, Philippe G Steg, Cathrine Wold Knudsen, Alan B Storrow, William T Abraham, Alberto Perez, Richard Kamin, Paul Clopton, Alan S Maisel, Peter A McCullough.   

Abstract

OBJECTIVE: Diabetes has been implicated in reduced myocardial compliance and changes in the intercellular matrix of the myocardium. We determined the effect of diabetes on B-type natriuretic peptide (BNP) concentrations in patients presenting to the emergency department with dyspnea. RESEARCH DESIGN AND METHODS: The Breathing Not Properly Multinational Study was a prospective evaluation of 1,586 patients. A subset of 922 patients was obtained and subdivided into the following groups: group 1 (n = 324), neither diabetes nor heart failure; group 2 (n = 107), diabetes and no heart failure; group 3 (n = 247), no diabetes and heart failure; group 4 (n = 183), both diabetes and heart failure; group 5 (n = 41), heart failure history with no diabetes; and group 6 (n = 20), heart failure history with diabetes. Patients from groups 1, 3, and 5 were matched to groups 2, 4, and 6, respectively, to have the same mean age, sex distribution, BMI, renal function, and New York Heart Association (NYHA) classification (for heart failure).
RESULTS: There was no significant difference in median BNP levels between diabetes and no diabetes among no heart failure patients (32.4 vs.32.9 pg/ml), heart failure patients (587 vs. 494 pg/ml), and those with a heart failure history (180 vs. 120 pg/ml). Receiver-operating characteristic curve analysis of the area under the curve for BNP was not different in diabetic versus nondiabetic patients (0.888 vs. 0.878, respectively). However, in a multivariate model, diabetes was an independent predictor of a final diagnosis of heart failure (odds ratio 1.51, 95% CI 1.03-2.02; P < 0.05).
CONCLUSIONS: History of diabetes does not impact BNP levels measured in patients with acute dyspnea in the emergency department. Despite the impact of diabetes on the cardiovascular system, diabetes does not appear to confound BNP levels in the emergency department diagnosis of heart failure. Copyright 2004 American Diabetes Association

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15451907     DOI: 10.2337/diacare.27.10.2398

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  7 in total

Review 1.  Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence.

Authors:  Stephen A Hill; Ronald A Booth; P Lina Santaguida; Andrew Don-Wauchope; Judy A Brown; Mark Oremus; Usman Ali; Amy Bustamam; Nazmul Sohel; Robert McKelvie; Cynthia Balion; Parminder Raina
Journal:  Heart Fail Rev       Date:  2014-08       Impact factor: 4.214

2.  Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes.

Authors:  L Tarnow; M-A Gall; B V Hansen; P Hovind; H-H Parving
Journal:  Diabetologia       Date:  2006-08-26       Impact factor: 10.122

Review 3.  Diabetes Mellitus and Heart Failure.

Authors:  Dimitris Tousoulis; Evangelos Oikonomou; Gerasimos Siasos; Christodoulos Stefanadis
Journal:  Eur Cardiol       Date:  2014-07

Review 4.  Glycemic control and treatment patterns in patients with heart failure.

Authors:  W H Wilson Tang
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

5.  The use of B-type natriuretic peptide in the management of patients with diabetes and acute dyspnoea.

Authors:  C Mueller; K Laule-Kilian; A Christ; A P Perruchoud
Journal:  Diabetologia       Date:  2006-02-16       Impact factor: 10.122

Review 6.  Utility of natriuretic peptide testing in the evaluation and management of acute decompensated heart failure.

Authors:  Jun R Chiong; Geoffrey T Jao; Kirkwood F Adams
Journal:  Heart Fail Rev       Date:  2010-07       Impact factor: 4.214

7.  The biological variation of N-terminal pro-brain natriuretic peptide in postmenopausal women with type 2 diabetes: a case control study.

Authors:  Susana González; Eric S Kilpatrick; Stephen L Atkin
Journal:  PLoS One       Date:  2012-11-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.